Antoni van Leeuwenhoek


Klinik

Standort der Organisation:
Amsterdam, Niederlande


Forschungsprojekte mit FAU-Wissenschaftlerinnen und Wissenschaftlern


TAPAS: Training Network on Automatic Processing of PAthological Speech
Dr. Mathew Magimai Doss
(01.11.2017 - 31.10.2021)


Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern


Go to first page Go to previous page 1 von 3 Go to next page Go to last page
Dork, T., Peterlongo, P., Mannermaa, A., Bolla, M.K., Wang, Q., Dennis, J.,... Geisler, J. (2019). Two truncating variants in FANCC and breast cancer risk. Scientific Reports, 9(1). https://dx.doi.org/10.1038/s41598-019-48804-y
Van De Putte, E.E.F., Otto, W., Hartmann, A., Bertz, S., Mayr, R., Bruendl, J.,... Van Rhijn, B.W.G. (2018). Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2018.05.007
van de Putte, E.E., Bosschieter, J., van der Kwast, T.H., Bertz, S., Denzinger, S., Manach, Q.,... van Rhijn, B.W. (2018). The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer. Bju International. https://dx.doi.org/10.1111/bju.14238
Klaassen, Z., Kamat, A.M., Kassouf, W., Gontero, P., Villavicencio, H., Bellmunt, J.,... Kulkarni, G.S. (2018). Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations. European Urology. https://dx.doi.org/10.1016/j.eururo.2018.06.024
Kasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F.,... Gronchi, A. (2017). An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology, 28(10), 2399-2408. https://dx.doi.org/10.1093/annonc/mdx323
Guo, Q., Burgess, S., Turman, C., Bolla, M.K., Wang, Q., Lush, M.,... Pharoah, P.D.P. (2017). Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology, 46(6), 1814-1822. https://dx.doi.org/10.1093/ije/dyx131
Shimelis, H., Mesman, R.L.S., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C.,... Couch, F.J. (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Research, 77(11), 2789-2799. https://dx.doi.org/10.1158/0008-5472.CAN-16-2568
Barrdahl, M., Rudolph, A., Hopper, J.L., Southey, M.C., Broeks, A., Fasching, P.,... Chang-Claude, J. (2017). Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. International Journal of Cancer, 141(9), 1830-1840. https://dx.doi.org/10.1002/ijc.30859
Muranen, T.A., Greco, D., Blomqvist, C., Aittomaki, K., Khan, S., Hogervorst, F.,... Nevanlinna, H. (2017). Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genetics in Medicine, 19(5), 599-603. https://dx.doi.org/10.1038/gim.2016.147
Pavel, M.E., Singh, S., Strosberg, J.R., Bubuteishvili-Pacaud, L., Degtyarev, E., Neary, M.P.,... Yao, J.C. (2017). Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncology, 18(10), 1411-1422. https://dx.doi.org/10.1016/S1470-2045(17)30471-0
Jiao, X., Aravidis, C., Marikkannu, R., Rantala, J., Picelli, S., Adamovic, T.,... Lindblom, A. (2017). PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget, 8(61), 102769-102782. https://dx.doi.org/10.18632/oncotarget.21800
Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M.K., Wang, Q.,... Neven, P. (2017). Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Research, 19(1). https://dx.doi.org/10.1186/s13058-017-0909-3
Fagerholm, R., Khan, S., Schmidt, M.K., Garcia-Closas, M., Heikkila, P., Saarela, J.,... Nevanlinna, H. (2017). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Oncotarget, 8(11), 18381-18398. https://dx.doi.org/10.18632/oncotarget.15110
Schmidt, M.K., Hogervorst, F., Van Hien, R., Cornelissen, S., Broeks, A., Adank, M.A.,... Easton, D.F. (2016). Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Journal of Clinical Oncology, 34(23), 2750-60. https://dx.doi.org/10.1200/JCO.2016.66.5844
Wyszynski, A., Hong, C.-C., Lam, K., Michailidou, K., Lytle, C., Yao, S.,... Cole, M.D. (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics, 25(17), 3863-3876. https://dx.doi.org/10.1093/hmg/ddw223
Hamdi, Y., Soucy, P., Adoue, V., Michailidou, K., Canisius, S., Lemacon, A.,... Simard, J. (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget, 7(49), 80140-80163. https://dx.doi.org/10.18632/oncotarget.12818
Zhao, Z., Wen, W., Michailidou, K., Bolla, M.K., Wang, Q., Zhang, B.,... Zheng, W. (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes & Control, 27(5), 679-93. https://dx.doi.org/10.1007/s10552-016-0741-6
Ghoussaini, M., French, J.D., Michailidou, K., Nord, S., Beesley, J., Canisus, S.,... Edwards, S.L. (2016). Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. American Journal of Human Genetics, 99(4), 903-911. https://dx.doi.org/10.1016/j.ajhg.2016.07.017
Horne, H.N., Chung, C.C., Zhang, H., Yu, K., Prokunina-Olsson, L., Michailidou, K.,... Figueroa, J.D. (2016). Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. PLoS ONE, 11(8). https://dx.doi.org/10.1371/journal.pone.0160316
Shi, J., Zhang, Y., Zheng, W., Michailidou, K., Ghoussaini, M., Bolla, M.K.,... Long, J. (2016). Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer, 139(6), 1303-1317. https://dx.doi.org/10.1002/ijc.30150

Zuletzt aktualisiert 2016-02-08 um 08:33